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Dopamine receptor alterations in female rats
with diet-induced decreased brain
docosahexaenoic acid (DHA):
interactions with reproductive status
Paul F. Davis1, Marlies K. Ozias1, Susan E. Carlson2–4, Gregory A. Reed1,
Michelle K. Winter1,4, Kenneth E. McCarson1,4, Beth Levant1,4
1Department of Pharmacology, Toxicology, and Therapeutics, 2Department of Dietetics & Nutrition,
3Department of Pediatrics, and 4Kansas Intellectual and Developmental Disabilities Research Center,
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Decreased tissue levels of n-3 (omega-3) fatty acids, particularly docosahexaenoic acid (DHA), are
implicated in the etiologies of non-puerperal and postpartum depression. This study examined the
effects of a diet-induced loss of brain DHA content and concurrent reproductive status on
dopaminergic parameters in adult female Long–Evans rats. An α-linolenic acid-deficient diet and
breeding protocols were used to produce virgin and parous female rats with cortical phospholipid
DHA levels 20–22% lower than those fed a control diet containing adequate α-linolenic acid.
Decreased brain DHA produced a significant main effect of decreased density of ventral striatal D2-
like receptors.Virgin females with decreased DHA also exhibited higher density of D1-like receptors
in the caudate nucleus than virgin females with normal DHA. These receptor alterations are similar
to those found in several rodent models of depression, and are consistent with the proposed
hypodopaminergic basis for anhedonia and motivational deficits in depression.
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Introduction
Polyunsaturated fatty acids (PUFAs) are a component
of the phospholipids that form the membranes of all
cells. In the membrane, PUFAs serve as precursors for
signaling molecules (e.g. prostaglandins and thromb-
oxanes), activate transcription factors and nuclear
receptors (e.g. PPARα and RXR), and influence the
physicochemical properties of the membrane, thus
affecting the function of membrane-bound proteins
such as receptors and ion channels.1,2 In the brain, the
n-3 (or omega-3) PUFA docosahexaenoic acid (DHA;
22:6n-3) is the most abundant, representing about 15%
of all lipids in that tissue.3 DHA accumulates in the
brain primarily during pre- and neonatal develop-
ment; it is supplied by the mother to the developing
fetus in utero, and to the neonate via breast milk.4,5
Inadequate accumulation of DHA in brain phospho-
lipids does not affect overall growth or brain weight;
however, sufficient DHA is necessary for optimal
brain development and neuronal function.6,7
Depression occurs almost twice as commonly in
females than in males,8 with the postpartum period
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DOI 10.1179/147683010X12611460764282representing a time of increased incidence of depression
in females.9 A number of clinical studies of PUFAs in
depression suggest a role for decreased n-3 PUFAs,
particularly DHA, in the pathogenesis of the disease.
Most notably, DHA content in the orbitofrontal cortex
was 22% lower in postmortem patients with major
depressive disorder compared to controls; this decrease
was even greater in depressed females than in males.10
Likewise, DHA levels were lower in the adipose tissue,
plasma, serum, or erythrocytes of depressed patients
than controls.11–16 Epidemiological studies also indicate
that lower levels of fish consumption, a major dietary
source of DHA and other n-3 PUFAs, are associated
with higher rates of depression.17–20 Furthermore, n-3
PUFA supplements improved depressive symptoms in
several clinical trials.21 Similar epidemiological and
clinicalfindingsimplicatedecreasedDHAintheetiology
of postpartum depression.22–26
Decreased dopaminergic function appears to con-
tribute to anhedonic behavior in several animal models,
and has been proposed to play a role in the pathogenesis
of depression (as reviewed elsewhere27–30). Of note,
concentrationsof thedopaminemetabolitehomovanillic
acid (HVA) in cerebrospinal fluid were decreased in
depressedpatientsandsuicidevictims,andwereinversely
related to depressed mood and psychomotor
retardation.31–34 Depression is also common in
Parkinson’s disease, a neurodegenerative disorder involv-
ing the loss of nigrostriatal dopamine neurons, and can
precede the onset of significant motor symptoms.35,36
Thus, decreased dopaminergic neurotransmission has
been hypothesized to underlie the anhedonia and
motivational deficits associated with the disorder.37
The percentage of DHA in brain phospholipids of
adult female rats can be decreased by roughly 20%,
similar to the decrease reported in depressed
humans,10 if the animals are fed an n-3 PUFA-
deficient diet for a sufficient period of time.38 This loss
of DHA occurred more rapidly in reproducing
females, presumably due to physiological demands of
pregnancy and lactation.39 Female rats with diet-
induced decreases in brain DHA exhibited decreased
hippocampal brain-derived neurotrophic factor
(BDNF) expression and altered regulation of the
hypothalamic–pituitary–adrenal (HPA) axis similar to
that reported in depression.40 In addition, parous
dams with decreased brain DHA exhibited shorter
latency to immobility in the forced swim test,40 an
effect opposite of that produced by antidepressant
drugs.41 While a confluence of genetic and
environmental factors may be required for the
development of depression,42 the similarity of these
effects with neurobiological findings in depressed
humans and in rodent models of depression suggests
that a decrease in brain DHA represents one of the
factors that can create a state of vulnerability that
contributes to the development the disease.
In view of the evidence supporting roles for n-3
PUFAs and dopamine in the pathogenesis of
depression, the higher prevalence of depression in
women, and the particular vulnerability to depression
conferred by the postpartum state, this study used a
rat model to examine the effects of a clinically-relevant
decrease in brain phospholipid DHA content and its
interactions with reproductive status (virgin or
parous) on the CNS dopamine systems in female rats.
The effects of these treatments on gene expression of
brain-derived neurotrophic factor (BDNF), a
mediator of plasticity in the mesolimbic system that
was increased in the nucleus accumbens of post-
mortem depressives43,44 and that modulates expression
of dopamine receptors,45,46 was also assessed. Finally,
to ascertain that the observed effects were not
secondary to DHA level-induced variation in estradiol
levels within the virgin or parous groups, serum
estradiol concentrations were also determined. We
show that a diet-induced reduction in brain DHA
content results in alterations in the density of
dopamine receptors independently of changes in
BDNF mRNA levels or regional dopamine content in
female rats and that the effects differ depending on
reproductive status.
Materials and methods
Animals
Experiments were conducted in accordance with the
NIH Guide for the Care and Use of Laboratory
Animals and were approved by the University of
Kansas Medical Center Institutional Animal Care and
Use Committee.
Adult, male and female Long–Evans rats (Harlan,
Indianapolis, IN, USA) were housed in a temperature-
and humidity-controlled animal facility with a 12-h
dark-light cycle (on at 06:00 h), and given food and
water ad libitum. Rats were obtained at least 5 days
prior to any treatments and were handled regularly.
Four separate cohorts of rats were used.
Experimental design
A between-groups design was used to assess the effects
of reproductive status (virgin or parous) and brain
DHA content (normal or decreased). Brain DHA
content was manipulated by feeding diets varying in n-3
PUFA content to effect (see below).
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uctive cycles (gestation and nursing), with the initial
mating occurring on postnatal day (P) 75–80. Dams
were placed on the experimental diets at the time of
the first mating. Litters were weighed and culled to
eight pups on P1, and weaned on P20. The second
mating occurred 8–10 days after weaning of the first
litter. Parous dams were euthanized on P20 after the
second litter. This treatment produces maximal
alterations in brain PUFA composition in dams fed
the deficient diet.39 Furthermore, the maternal brain
was examined at the end of the period of greatest
offspring demand for DHA (i.e. weaning), which in
this respect is similar to the postpartum period in
humans (1–3 months after birth)47,48 and, thus,
parallels the clinical onset of postpartum depression.49
Virgin females with normal DHA were fed the
control diet for 13 weeks beginning at P75–80. This
treatment duration corresponds to the time required
for two reproductive cycles and is based on our prior
finding that brain PUFA composition does not vary in
virgin adult females fed the control diet for periods
ranging from 6 weeks to 6 months.39 Virgin females
with decreased DHA were produced by feeding the
deficient diet for 6 months, the treatment required to
produce a decrease in brain DHA comparable to that
observed in parous dams fed the deficient diet.39
Treatment of virgin females fed the deficient diet
started at P56–60, thus bracketing the treatment
period for the other groups. Virgin females were
euthanized during diestrus, determined by vaginal
lavage performed at the same time each day
(09:00–10:00 h). Once regular cycling was confirmed,
virgins were considered to be in diestrus on the day
following estrus, and were not subjected to vaginal
lavage on the day of euthanasia.
At the completion of the diet and breeding
treatments, and between 10:00 and 11:00 h, rats were
euthanized by decapitation. Trunk blood was
collected, allowed to clot, centrifuged, and serum
collected. Brains were rapidly removed and frozen on
dry ice. Brain regions of interest were isolated by
freehand dissection on ice according to a modification
of the methods of Glowinski and Iversen.50 All
samples were stored at –70ºC.
Experimental diets
The control diet was prepared from a purified basal
mix (TD00235; Teklad, Indianapolis, IN, USA) with
pure unhydrogenated soybean oil (70 g/kg), and was
identical in composition to Teklad AIN-93G, which
meets all current nutrient standards for rat pregnancy
and growth.51 The deficient diet was the same as the
control diet, except it was prepared with safflower oil
(66.5 g/kg) and soybean oil (3.5 g/kg) as previously
described.40 Analysis of the fatty acid composition of
the diets indicated that the control diet contained 4.20
g/kg α-linoleic acid and 33.81 g/kg linoleic acid. The
deficient diet contained 0.38 g/kg α-linoleic acid and
45.96 g/kg linoleic acid.
Brain total phospholipid fatty acid composition
As previously described,52 lipids were extracted from
occipital cortex, a brain region not required for the
determination of other end-points but exhibiting diet-
induced changes in DHA content similar to whole
brain. Phospholipids were isolated by thin layer
chromatography. The band containing total phospho-
lipids was removed and transmethylated with boron
trifluoride methanol (Sigma, St Louis, MO, USA) to
yield fatty acid methyl esters. Individual fatty acid
methyl esters were separated on a Varian 3400 gas
chromatograph with an SP-2330 capillary column (30
m; Supelco, Inc., Belfonte, PA, USA), with helium
used as the carrier gas. The resulting peaks were
identified by comparison to authentic standards
(PUFA 1 and PUFA 2, Supelco, Inc.; 22:5n-6, Nu-
Chek Prep, Elysian, MN, USA) and expressed as
weight percent of total fatty acids on the basis of peak
areas of individual fatty acids in a mixture of fatty
acids of known weight (Supelco 37 mixture).
Receptor binding assays
Dissected brain tissue was homogenized in 20 vol
(w/v) of buffer (50 mM Tris; pH 7.4 at 23ºC) using a
PRO homogenizer (setting 4 for 10 s). The crude
homogenate was centrifuged twice (15 min at 48,000
g), and pellet resuspended each time in 20 vol of
buffer. The final pellet was resuspended in the
appropriate concentration for each assay in the
respective assay buffer.
The affinity and density of D1-like receptors were
assessed by Scatchard analysis using four
concentrations of [N-methyl-3H]-SCH 23390 (87
Ci/mmol; 0.04–1.2 nM; GE Healthcare, Piscataway,
NJ, USA) in an equilibrium, filtration assay as
previously described.53 The assay buffer was 50 mM
Tris, 120 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, pH 7.4 at 23ºC. Non-specific binding was
defined in the presence of 1 µM (+)-butaclamol.
Membrane protein concentrations were determined by
the BCA method (Pierce, Rockford, IL, USA) and
were ~50 µg/tube. Assay tubes were incubated at 23ºC
for 90 min. The reaction was terminated by rapid
vacuum filtration. Bound radioactivity was quantified
using a Beckman LS-6500 liquid scintillation counter.
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analyzed for KD and Bmax using SigmaPlot (v8.0.2) in
accordance with the methods of Bylund and
Yamamura.54
The affinity and density of D2-like receptors were
assessedusing[3H]-spiperone(21Ci/mmol;0.03–0.7nM;
GE Healthcare) as previously described.53 Assays were
performed as described for D1-like receptor binding
except the assay buffer was 50 mM Tris, 5 mM KCl, 2
mM CaCl2, 1 mM MgCl2, pH 7.4 at 23ºC.
D3-receptor binding was assessed using [3H]-PD
128907 as previously described.55 Due to the limited
quantity of ventral striatal tissue and the low density of
D3 sites, the initial binding analysis was performed using
a single concentration of (+)-[N-propyl-2,3-3H]-PD
128907 (112 Ci/mmol; 0.7 nM; Amersham, Arlington
Heights, IL, USA). Assays were performed as described
above except the assay buffer was 50 mM Tris, 1 mM
EDTA,pH7.4at23ºC;non-specificbindingwasdefined
by 1 µM spiperone, the membrane protein concentration
was ~200 µg/tube, and the incubation time was 3 h.
Becausenosignificantdifferenceswereobservedbetween
groups in the single-point analysis, further assessment of
D3 binding by Scatchard analysis was not performed.
Measurement of monoamine neurotransmitters and
metabolites
Concentrations of dopamine, dihydroxyphenylacetic acid
(DOPAC), and HVA were quantified using an isocratic
HPLC-EC system (ESA Coulochem III, Chelmsford,
MA, USA) coupled to a Coulochem III dual-channel
electrochemical array detector (ESA Inc., Chelmsford,
MA; Model 5100A, E1 –150 mV and E2 +275 mV using a
5011dualanalyticalcell)aspreviouslydescribed.40Tissues
were extracted in perchloric acid, diluted with mobile
phase, and analytes separated using a C18 reverse phase
column (ESA Inc., HR-80, 4.6 mm × 80 mm, 3 µm
particles) with a citrate–acetate mobile phase containing
6.0% methanol and 0.35 mM 1-octane-sulfonic acid (pH
4.1). The flow rate was 1.8 ml/min. The internal standard
was 3,4-dihydroxybenzylamine. Protein concentration of
the extracted tissue was determined by the BCA method
(Pierce). Monoamine concentrations are expressed as
nanogram per milligram protein. Neurotransmitter
turnover was calculated as the ratio of the metabolites to
the neurotransmitter.
Solution hybridization – nuclease protection assays for
BDNF mRNAs
Total cellular RNAs were extracted from ventral
striatal and caudate nucleus tissue samples using a
rapid guanidinium isothiocyanate phenol/chloroform
method. The resultant total RNAs were analyzed for
BDNF and β-actin mRNA levels by solution
hybridization – nuclease protection assays using [32P]-
labeled antisense cRNA probes as previously
described.56,57 Specific mRNAs were quantified by
comparison to cRNA quantitation standards and are
reported as picogram BDNF mRNA per nanogram β-
actin mRNA.
Estradiol radioimmunoassay
Serum estradiol concentrations were determined using
an estradiol Coat-a-Count radioimmunoassay kit
(Siemens/Diagnostic Products Corp., Los Angeles,
CA, USA).
Data analysis
Reproductive status and brain phospholipid DHA
content were used as the descriptors for the
independent variables, reflecting the experimental
approach of subjecting the rats to the diet treatment to
effect, rather than for a specified period of time. Data
are expressed as the mean ± SEM. Data were analyzed
for statistically significant effects by two-way ANOVA
with factors of brain DHA content and reproductive
status (Systat, v10.2). Significant effects were further
analyzed post-hoc using one-way ANOVA with all
treatment groups, followed by the Tukey–Kramer
multiple comparisons test. Differences between groups
were considered significant at P < 0.05.
Results
Cortical phospholipid fatty acid composition
Treatment of virgin females with the deficient diet for
6 months decreased the percentage of DHA in
cortical phospholipids by 20% compared to virgin
females fed the control diet. The decrease in DHA
was accompanied by a 6.4-fold compensatory
increase in the percentage of docosapentaenoic acid
(DPA; 22:5n-6) compared to virgin females fed the
control diet. The percentage of arachidonic acid
(20:4n-6) was not altered. These diet-induced
changes in brain fatty acid composition concur with
previous studies.39,40,58 Similar changes in phospho-
lipid fatty acid composition were observed in parous
dams fed the diets to the period of time required to
complete two reproductive cycles, also in agreement
with previous studies.39,40 Representative data from
one of the four cohorts of rats used in these experi-
ments are shown in Table 1.
Body weight
As previously reported,40 a significant main effect of
reproductive status on body weight at the end of the
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way ANOVA (P < 0.05), with parous dams having 6%
higher body weight than virgin females. There was no
main effect of diet treatment (Fig. 1).
Regional dopamine receptor binding
In the ventral striatum (nucleus accumbens and olfactory
tubercle), two-way ANOVA indicated a significant main
effect of brain DHA content on D2-like receptor binding
density (Bmax; P<0.01), and significant main effects of
reproductive status (P < 0.05) and brain DHA content
(P < 0.01) on D2-like receptor affinity (KD; Table 2).
Post-hoc analysis indicated that the density of D2-like
receptors in ventral striatum was 37% lower in parous
dams with decreased DHA than in parous dams with
normal DHA (P < 0.05). The density of D2-like
Nutritional Neuroscience 2010 Vol 13 No 4 165
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Table 1 Effects of diet and breeding treatments on the percentage of docosahexaenoic acid (DHA; 22:6n-3),
docosapentaenoic acid (DPA; 22:5n-6), and arachidonic acid (AA; 20:4n-6) in cortical phospholipids of female rats
Group DHA DPA AA
(Percentage of total fatty acids)
Virgin–normal DHA 15.0 ± 0.32 0.31 ± 0.014 10.8 ± 0.16
Virgin–decreased DHA 12.1 ± 0.35a 2.3 ± 0.027a 11.3 ± 0.15
Parous–normal DHA 14.6 ± 0.71b 0.46 ± 0.24b 11.8 ± 0.38
Parous–decreased DHA 11.5 ± 0.33a,b 2.2 ± 0.090a,c 11.6 ± 0.42
Data are presented as the mean ± SEM (n = 6 or 7 per group) and are representative of those obtained from one of the four
cohorts of rats used in these studies.
aDifferent from Virgin–normal DHA (P < 0.05).
bDifferent from Virgin-decreased DHA (P < 0.05).
cDifferent from Parous–normal DHA (P < 0.05).
Virgin females with normal DHA were fed the control diet for 13 weeks, corresponding to two reproductive cycles, beginning at
P75–80. Virgin females with decreased DHA were produced by feeding the deficient diet for 6 months, starting at P56–60, thus
bracketing the treatment period for the other groups. Parous dams underwent two sequential reproductive cycles (gestation and
nursing), beginning at P75–80, while being fed either the control or deficient diets.
Figure 1 Effects of diet and breeding treatments on body
weights in female rats. Data are presented as the
mean ± SEM (n = 15 per group). Body weight was
determined at the completion of the diet and
breeding treatment immediately prior to
euthanasia, and is representative of those
obtained from each of the four cohorts of rats used
in these studies. *Different from Virgin–normal
DHA (P < 0.05). These data were previously
reported in Levant et al.40
Table 2 Effects of brain DHA content and reproductive
status on the affinity and density of dopamine
receptors in the ventral striatum (nucleus
accumbens and olfactory tubercle) and caudate-
putamen
Reproductive status/ Bmax (fmol/ KD (nM)
brain DHA content mg protein)
Ventral striatum
D1-like receptors
Virgin–normal DHA 455 ± 33 0.27 ± 0.010
Virgin–decreased DHA 470 ± 25 0.25 ± 0.012
Parous–normal DHA 483 ± 7 0.23 ± 0.012
Parous–decreased DHA 429 ± 21 0.24 ± 0.019
D2-like receptors
Virgin–normal DHA 194 ± 18 0.29 ± 0.047
Virgin–decreased DHA 141 ± 18 0.23 ± 0.036
Parous–normal DHA 239 ± 36b 0.50 ± 0.072b
Parous–decreased DHA 150 ± 20c 0.26 ± 0.057c
Caudate nucleus
D1-like receptors
Virgin–normal DHA 501 ± 27 0.19 ± 0.010
Virgin–decreased DHA 599 ± 24a 0.22 ± 0.008
Parous–normal DHA 615 ± 20a 0.21 ± 0.009
Parous–decreased DHA 567 ± 14 0.18 ± 0.007b
D2-like receptors
Virgin–normal DHA 276 ± 23 0.22 ± 0.030
Virgin–decreased DHA 251 ± 11 0.23 ± 0.024
Parous–normal DHA 268 ± 25 0.20 ± 0.031
Parous–decreased DHA 289 ± 21 0.22 ± 0.027
Data are presented as the mean ± SEM (n = 7–10 per
group). D1-like receptor binding was determined using [3H]-
SCH 23390. D2-like receptor binding was determined using
[3H]-spiperone.
aDifferent from Virgin–normal DHA (P < 0.05).
bDifferent from Virgin-decreased DHA (P < 0.05).
cDifferent from Parous–normal DHA (P < 0.01).receptors in the ventral striatum of virgin females with
decreased DHA was 27% lower than in virgin females
with normal DHA, but was not quite statistically
significant (P = 0.069). The affinity of D2-like sites in
this brain region was roughly 2-fold lower in parous
dams with normal DHA than in parous dams with
decreased DHA (P < 0.05) or in virgin females with
decreased DHA (P < 0.05). The affinity and density of
D1-like receptors in the ventral striatum were not
affected by reproductive status or brain DHA content
(Table 3). Single-point binding assays with [3H]-PD
128907 indicated that the concentrations of D3
receptors in the ventral striatum were 16.1 ± 0.54
fmol/mg protein in the virgin-normal DHA group,
16.2 ± 1.23 fmol/mg protein in the virgin-decreased
DHA group, 16.4 ± 0.74 fmol/mg protein in the
parous-normal DHA group, and 15.5 ± 1.16 fmol/mg
protein in the parous-decreased DHA group; and were
not different between groups.
In the caudate-putamen, two-way ANOVA
indicated a significant interaction of reproductive
status and brain DHA content on D1-like receptor
density (P < 0.01) and affinity (P < 0.01; Table 3).
Post-hoc analysis indicated that the density of D1-like
receptors in the caudate-putamen was 20% higher in
virgin females with decreased DHA compared to
virgin females with normal DHA (P < 0.05). The
density of D1-like receptors was also 23% higher in
parous dams with normal DHA compared to virgin
females with normal DHA (P < 0.05). In addition, the
affinity of D1-like receptors was 10% higher in parous
dams with decreased DHA compared to virgin
females with decreased DHA (P < 0.05). The affinity
and density of D2-like receptors in the caudate-
putamen were not affected by reproductive status or
brain DHA content.
Regional dopamine concentrations and turnover
No effects of reproductive status or brain DHA content
were detected on the concentrations of dopamine and its
metabolites in the ventral striatum, caudate-putamen, or
substantia nigra/ventral tegmental area, nor were there
anysignificantdifferencesindopamineturnover(Table3).
BDNF gene expression
No effects of reproductive status or brain DHA
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Table 3 Effects of brain DHA content and reproductive status on the concentrations of dopamine, DOPAC, and HVA in
ventral striatum (nucleus accumbens and olfactory tubercle), caudate-putamen, and substantia nigra/ventral
tegmental area
Reproductive status/brain DHA content Dopamine DOPAC HVA Turnover
(ng/mg protein)
Ventral striatum
Virgin–normal DHA 40 ± 3.2 15 ± 0.70 25 ± 2.2 1.1 ± 0.10
Virgin–decreased DHA 39 ± 3.1 18 ± 1.3 26 ± 1.4 1.2 ± 0.09
Parous–normal DHA 44 ± 3.8 17 ± 1.0 25 ± 1.6 1.1 ± 0.12
Parous–decreased DHA 42 ± 2.5 15 ± 1.0 24 ± 1.6 1.0 ± 0.11
Caudate nucleus
Virgin–normal DHA 84 ± 5.0 21 ± 1.9 26 ± 0.69 0.59 ± 0.06
Virgin–decreased DHA 88 ± 8.6 23 ± 2.1 27 ± 1.6 0.61 ± 0.06
Parous–normal DHA 84 ± 5.9 22 ± 2.8 28 ± 2.6 0.59 ± 0.04
Parous–decreased DHA 100 ± 8.9 22 ± 1.6 27 ± 1.8 0.52 ± 0.04
Substantia nigra/ventral tegmental area
Virgin–normal DHA 9.0 ± 0.70 6.5 ± 1.0 12 ± 0.72 2.3 ± 0.36
Virgin–decreased DHA 7.6 ± 0.71 7.5 ± 0.90 11 ± 0.84 2.8 ± 0.46
Parous–normal DHA 9.7 ± 0.99 6.5 ± 0.73 11 ± 0.95 2.2 ± 0.43
Parous–decreased DHA 9.5 ± 1.1 5.9 ± 0.77 11 ± 0.66 2.2 ± 0.49
Data are presented as the mean ± SEM (n = 10 or 11 per group).No significant differences between groups were detected by ANOVA.
Table 4 Effects of brain DHA content and reproductive
status on the concentrations of BDNF mRNA in
ventral striatum (nucleus accumbens and
olfactory tubercle) and caudate-putamen
Reproductive status/ BDNF mRNA
brain DHA content (pg/ng β-actin mRNA)
Ventral striatum
Virgin–normal DHA 11.5 ± 2.1
Virgin–decreased DHA 12.1 ± 3.2
Parous–normal DHA 12.5 ± 1.7
Parous–decreased DHA 14.6 ± 1.3
Caudate nucleus
Virgin–normal DHA 16.6 ± 2.2
Virgin–decreased DHA 16.0 ± 2.0
Parous–normal DHA 14.2 ± 1.6
Parous–decreased DHA 16.0 ± 1.1
Data are presented as the mean ± SEM (n = 10–12 per
group). No significant differences between groups were
detected by ANOVA.content were detected on the concentrations of BDNF
mRNA in the ventral striatum or caudate-putamen
(Table 4).
Serum estradiol
Two-way ANOVA indicated a significant main effect
of reproductive status on serum estradiol concent-
rations (P < 0.001), which were 30–45% lower in
parous dams than in virgin females. There was no
effect of brain DHA content on estradiol levels
between the virgin or parous groups (Fig. 2).
Discussion
The effects of a diet-induced reduction of brain
phospholipid DHA content was assessed in diestrus
virgin female rats and in bi-parous dams at the time of
weaning. The present data demonstrate alterations in
regional dopamine receptor density, thus extending
findings on the neurobiological effects of a diet-
induced decrease in brain DHA content in adult
female animals to the dopamine system. Levels of
BDNF mRNA in the ventral striatum (nucleus
accumbens and olfactory tubercle) and caudate-
putamen were not altered by the diet and breeding
treatments, indicating that modulation of gene
expression for this neurotrophic factor differs in these
brain regions from hippocampus, where these
treatments increased expression of BDNF.40 Although
protein concentrations need not necessarily reflect
levels of mRNA, the present data suggest that the
effects of the diet-induced changes in brain DHA
produced in this study differ from findings in
depression where BDNF concentrations were
decreased in the nucleus accumbens.43 Serum estradiol
levels were not different between diet groups.
Accordingly, neither the dopamine receptor
alterations reported here, nor the previously reported
effects such as altered hippocampal BDNF expression
and HPA axis regulation,40 can be attributed to diet-
induced variation in estradiol levels within the virgin
or parous groups or to early re-instatement of estrous
cycling in the lactating dams. Furthermore, previous
findings rule out diet-induced variation in overall
health, weight gain, and maternal offspring burden as
contributing factors in the observed effects.40
A diet-induced decrease brain DHA content
produced a decrease in the density of D2-like dopamine
receptors in the ventral striatum, which was greater in
magnitude in parous dams than in virgin females, where
the effect was not quite significant. This observation is
consistent with the proposed hypo-activity of the
mesolimbic dopamine system in depression.27,29,30
However,arecentstudyindrug-naïvepatientswithmajor
depressive disorder found no differences in the density of
D2 receptors in either the ventral striatum or the caudate
nucleus.59Evenso,densitiesof D2-likereceptorsormRNA
in the nucleus accumbens were decreased in several
putativerodentmodelsof depressionsuchaschronicmild
stress-induced anhedonia and the socially-isolated
Flinders sensitive line rat,60,61 suggesting that hypo-activity
of the mesolimbic dopamine system may have differing
underlying bases in humans and rodents. The
Wistar–Kyotorat,anotherrodentdepressionmodel,also
exhibiteddecreasedD2bindinginthenucleusaccumbens
core compared to the Wistar progenitor strain, though
D2 binding was also increased in the nucleus accumbens
shell.62 In addition, decreased density of D2 receptors in
the nucleus accumbens was detected in rats subjected to
inescapable stress in the learned helplessness model, but
was present regardless of whether the rats exhibited
subsequent learned helplessness behaviors.63 Some of
these putative animal models of depression also
exhibited increased61,63 or decreased64 levels of D1
receptor binding or mRNA in this brain region, which
was not altered in either virgin or parous rats with
decreased brain DHA.
In addition to the changes in ventral striatal D2-like
receptor density, virgin females with a diet-induced
decrease in brain DHA content exhibited increased
density of D1-like receptors in the caudate-putamen.
An increase in D1–like receptors in this brain region,
without an alteration in D2 receptor density was also
reported in the chronic mild stress-induced anhedonia
Nutritional Neuroscience 2010 Vol 13 No 4 167
Davis et al. DHA and dopamine receptors
Figure 2 Effects of brain DHA content and reproductive
status on serum estradiol concentrations. Data are
presented as the mean ± SEM (n = 9–12 per group).
*Different from Virgin–normal DHA (P < 0.05).
†Different from Virgin–decreased DHA (P < 0.05)model of depression.60 Likewise, higher levels of D1
receptor mRNA were detected in the caudate-
putamen of the Flinders sensitive line rat, with or
without social isolation, although this rodent
depression model also exhibited decreased density of
D2 receptor mRNA in this brain region when socially
isolated.61 In the inescapable stress-learned
helplessness model, an increase in D1 binding in the
caudate-putamen, with no change in D2 binding, was
observed after inescapable stress, but only in the
subset of rats that did not exhibit subsequent learned
helplessness.63 However,D 1 and D2 binding in the
caudate-putamen were both lower in the
Wistar–Kyoto rat depression model,62,64 and lower
densities of D1 receptors were observed in the caudate
nucleus of patients with major depression in PET
imaging studies,65,66 suggesting that further research is
required to resolve the contribution of specific
dopamine receptor alterations in this brain region to
the depressive phenotype.
Dopamine receptor affinity and density are known
to be regulated by dopaminergic neurotransmission
and by BDNF.45,46,67 However, the changes in
dopamine receptor density observed in this study
occurred in the absence of concurrent changes of
regional dopamine concentration and turnover or
changes in BNDF gene expression, indicating that
other mechanism are involved. A decrease in brain
DHA content, which occurs throughout the brain,
affects a variety of systems by multiple mechanisms
involving altered membrane properties, changes in
intra- and intercellular signaling, and modulation of
gene transcription (see Introduction).1,2 The receptor
changes reported here thus likely represent the net
effect of these changes, the specific nature of which
must be determined in future studies.
Conclusions
The present findings demonstrate that a diet-induced
reduction in brain DHA content in female rats results in
alterations in the density of dopamine receptors that are
similar to those found in several rodent models of
depression, differ depending on reproductive status, and
occur independently of changes in BDNF mRNA levels
or regional dopamine content.
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